Document Detail


Clozapine-withdrawal catatonia.
MedLine Citation:
PMID:  20587767     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Case reports in which abrupt clozapine discontinuation led to a return of psychosis, autonomic instability, or catatonia have been previously presented in the literature.
OBJECTIVE: The authors report on symptom presentation and resolution in a case of abrupt withdrawal of clozapine medication.
METHOD: The authors describe the condition and history of the patient, a 49-year-old woman with schizophrenia, the medical support she received, and the re-initiation of her clozapine medication.
RESULTS: Symptoms of catatonia and autonomic instability resolved by Day 4 of treatment.
CONCLUSION: Patients and their caregivers need to be educated about the effects of abrupt cessation of clozapine administration.
Authors:
Mitali Wadekar; Saba Syed
Related Documents :
10468677 - Patterns of consultation and treatment for heartburn: findings from a singaporean commu...
16184217 - Patients' perceptions of isotretinoin, depression and suicide--a qualitative study.
794717 - Interim report on clinic intake and safety data collected from 17 nida-funded naltrexon...
3611687 - Recollection of childhood events in adults with irritable bowel syndrome.
7632427 - Medical disorders of adults with mental retardation: a population study.
12088347 - Medications taken by 26-year-olds.
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Psychosomatics     Volume:  51     ISSN:  1545-7206     ISO Abbreviation:  Psychosomatics     Publication Date:    2010 Jul-Aug
Date Detail:
Created Date:  2010-06-30     Completed Date:  2010-10-25     Revised Date:  2012-04-24    
Medline Journal Info:
Nlm Unique ID:  0376506     Medline TA:  Psychosomatics     Country:  United States    
Other Details:
Languages:  eng     Pagination:  355-355.e2     Citation Subset:  IM    
Affiliation:
Dept. of Psychiatry and Biobehavioral Sciences, UCLA, UCLA-Psychiatry Residency Program Education Office (116A3), 16111 Plummer St., Bldg. 10, North Hills, CA 91343, USA. mitaliwadekar@gmail.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antipsychotic Agents / adverse effects*,  therapeutic use
Catatonia / chemically induced*,  drug therapy,  psychology
Clozapine / adverse effects*,  therapeutic use
Female
Follow-Up Studies
Humans
Middle Aged
Schizophrenia / drug therapy*
Schizophrenic Psychology
Substance Withdrawal Syndrome / drug therapy*,  psychology
Suicide, Attempted / psychology
Chemical
Reg. No./Substance:
0/Antipsychotic Agents; 5786-21-0/Clozapine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Neuroleptic malignant syndrome: further lessons from a case report.
Next Document:  Rhabdomyolysis After LSD Ingestion.